Does parvovirus B19 IgG positivity with negative IgM usually indicate past infection?

Parvovirus B19 serology is best interpreted in relation to antibody timing, symptoms, immune status, and hematologic findings. For an 83-year-old man, an isolated IgG-positive/IgM-negative result is usually evidence of remote infection rather than active acute disease.

Clinical interpretation

• IgG-positive/IgM-negative serology is strongly consistent with prior exposure and durable immune memory. B19 IgG generally appears about 2 weeks after infection and persists long term, often lifelong.
• Acute infection is less likely because B19 IgM, which typically emerges around days 10–14, usually declines over approximately 2–4 months. Thus, absent IgM in the usual diagnostic setting argues against a recent acute infection.
• This pattern is probabilistic rather than absolute: IgM can be absent if testing occurs very early, after IgM has waned, or when antibody production is impaired.

Mechanistic and testing considerations

• B19 can leave low-level viral DNA detectable for months to years after clinical recovery and IgG development. Therefore, a positive qualitative PCR alone does not necessarily establish active disease; viral burden, serial results, symptoms, and blood counts are important.
• In people with immunocompromise, B19-specific IgM and/or IgG responses may be reduced or absent, making serology less reliable and increasing the value of PCR in the appropriate clinical context.

Clinical implications

• If there are no compatible symptoms or unexplained anemia, isolated IgG generally needs no acute-infection workup.
• If recent exposure, compatible illness, anemia, or impaired immunity raises concern, repeat serology in 2–3 weeks and/or B19 DNA PCR can clarify timing and activity.

Bottom line

• B19 IgG positivity with negative IgM usually reflects past infection/immune memory, not acute parvovirus B19 infection; exceptions depend chiefly on testing timing and impaired antibody responses.